Search

Search Constraints

You searched for: Author/Creator Formica, V.

Search Results

1. 1571 Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy. (September 2015)

2. 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study. (September 2015)

3. A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma. (January 2021)

5. OC.01.4 EUS PREDICTIVE FACTORS OF RECURRENCE IN PATIENTS WITH LOCAL ADVANCED RECTAL CANCER. (24th February 2016)

6. OC.06.6 HEPCIDIN UPREGULATION IN COLORECTAL CANCER ASSOCIATES WITH ACCUMULATION OF REGULATORY MACROPHAGES AND EPITHELIAL–MESENCHYMAL TRANSITION AND CORRELATES WITH PROGRESSION OF THE DISEASE. (March 2023)

7. P.03.5 REPETITION OR SIMULTANEOUS SAMPLING OF PRIMARY AND METASTATIC LESIONS IMPROVE DIAGNOSTIC ACCURACY OF EUS-FNA IN THE ASSESSMENT OF SUSPECTED NEOPLASTIC PANCREATIC MASS. (24th February 2016)